Indane modulators of glucocorticoid receptor, AP-1, and/or NF/kB activity and use thereof
申请人:Duan Jingwu
公开号:US20070185056A1
公开(公告)日:2007-08-09
Novel non-steroidal compounds are provided that are useful in treating diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF-κB activity including obesity, diabetes, inflammatory and immune diseases having the structure of formula (I):
or enantiomers, diastereomers, or a pharmaceutically-acceptable salt, or hydrate, thereof, where X is -A
1
QA
2
-; Q is a bond, —C(═O)—, —OC(O)—, —C(═O)NR
5
—, —SO
p
—, —SO
p
NR
5
—, —C(O)O—, —NR
5
C(O)—, —OC(O)NR
5
—, —NR
5
C(O)O—, —S(O)
p
NR
5
C(O)—, —C(O)NR
5
S(O)
p
— —NR
5
S(O)
p
—, or —NR
5
C(═O)NR
6
—. Y is selected from hydrogen, C
1-4
alkyl, OR
16
, substituted C
1-6
alkyl, cycloalkyl, aryl, heterocyclo and heteroaryl. A
1
and A
2
are independently selected from a bond, C
1-3
alkylene, or C
1-3
alkenylene, and R
1
-R
11
are defined herein. Also provided are pharmaceutical compositions, combinations, and methods of treating obesity, diabetes and inflammatory- or immune-associated diseases comprising said compounds.
提供了一种新型的非甾体化合物,可用于治疗与糖皮质激素受体、AP-1和/或NF-κB活性调节相关的疾病,包括肥胖、糖尿病、炎症性和免疫性疾病,其具有以下结构的化学式(I):
或其对映体、非对映体、药用可接受的盐或水合物,其中X为-A
1
QA
2
-;Q为键,—C(═O)—,—OC(O)—,—C(═O)NR
5
—,—SO
p
—,—SO
p
NR
5
—,—C(O)O—,—NR
5
C(O)—,—OC(O)NR
5
—,—NR
5
C(O)O—,—S(O)
p
NR
5
C(O)—,—C(O)NR
5
S(O)
p
—,—NR
5
S(O)
p
—,或—NR
5
C(═O)NR
6
—。Y从氢、C
1-4
烷基、OR
16
、取代的C
1-6
烷基、环烷基、芳基、杂环烷基和杂芳基中选择。A
1
和A
2
独立选择自键、C
1-3
烷基或C
1-3
烯基,R
1
-R
11
在此定义。还提供了包含所述化合物的药物组合物、组合物和治疗肥胖、糖尿病和炎症性或免疫相关疾病的方法。